Gracell Biotechnologies Inc.

(NASDAQ:GRCL) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Gracell Biotechnologies Inc is a clinical-stage biopharmaceutical company focused on developing and discovering cell and gene therapies to address and fulfil unmet medical needs in the treatment of cancer.

Contact Information

Website: www.gracellbio.com
Email: Gracie.tong@gracellbio.com
Main Phone: +86 51262626701
Address: 218 Sangtian Street
Address 2: Building 12, Block B, Phase II,
City / Town: Suzhou
Country: CN
Postal Code: 215123

Issuer Information

Exchange: NGS
CEO: Wei William Cao
Employees: 160

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A